| Dr Krista Nicole Larson, MD | |
|
301 Ne Knott St Ste 4102, Portland, OR 97212-3014 | |
| (305) 562-0588 | |
| (352) 265-1107 |
| Full Name | Dr Krista Nicole Larson |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 7 Years |
| Location | 301 Ne Knott St Ste 4102, Portland, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245693902 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD200083 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Knott Street Dermatology Pc | 8325050859 | 5 |
News Archive
USA Today: "The number of soldiers forced to leave the Army solely because of a mental disorder has increased by 64% from 2005 to 2009 and accounts for one in nine medical discharges, according to Army statistics.
A new study to be presented at CHEST Congress 2019 Thailand in Bangkok shows a significant decrease in teen driving accidents when school start is delayed. Researchers from Farwaniya Hospital in Kuwait and Boston Children's Hospital studied the impact of a 50-minute delay in high school start times in one of the largest school districts in the U.S.
Vertex Pharmaceuticals Incorporated announced today that the European Commission has approved KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces the publication of an article, entitled "A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series," authored by Dr. Matthew C. Foote, Dr. Bryan H. Burmeister, Janine Thomas, and Dr. B. Mark Smithers, in the current issue of the peer-reviewed journal, Melanoma Research (20(1):48-51, February 2010).
Luisa Iruela-Arispe, PhD, the Stephen Walter Ranson Professor of Cell Biology and chair of Cell and Developmental Biology, is the North American coordinator for an international collaboration that has received a five-year, $7 million Transatlantic Networks of Excellence Program award from the Leducq Foundation.
› Verified 5 days ago
| Entity Name | Knott Street Dermatology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891741864 PECOS PAC ID: 8325050859 Enrollment ID: O20060626000191 |
News Archive
USA Today: "The number of soldiers forced to leave the Army solely because of a mental disorder has increased by 64% from 2005 to 2009 and accounts for one in nine medical discharges, according to Army statistics.
A new study to be presented at CHEST Congress 2019 Thailand in Bangkok shows a significant decrease in teen driving accidents when school start is delayed. Researchers from Farwaniya Hospital in Kuwait and Boston Children's Hospital studied the impact of a 50-minute delay in high school start times in one of the largest school districts in the U.S.
Vertex Pharmaceuticals Incorporated announced today that the European Commission has approved KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces the publication of an article, entitled "A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series," authored by Dr. Matthew C. Foote, Dr. Bryan H. Burmeister, Janine Thomas, and Dr. B. Mark Smithers, in the current issue of the peer-reviewed journal, Melanoma Research (20(1):48-51, February 2010).
Luisa Iruela-Arispe, PhD, the Stephen Walter Ranson Professor of Cell Biology and chair of Cell and Developmental Biology, is the North American coordinator for an international collaboration that has received a five-year, $7 million Transatlantic Networks of Excellence Program award from the Leducq Foundation.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Krista Nicole Larson, MD 301 Ne Knott St, Portland, OR 97212-3014 Ph: (503) 253-3910 | Dr Krista Nicole Larson, MD 301 Ne Knott St Ste 4102, Portland, OR 97212-3014 Ph: (305) 562-0588 |
News Archive
USA Today: "The number of soldiers forced to leave the Army solely because of a mental disorder has increased by 64% from 2005 to 2009 and accounts for one in nine medical discharges, according to Army statistics.
A new study to be presented at CHEST Congress 2019 Thailand in Bangkok shows a significant decrease in teen driving accidents when school start is delayed. Researchers from Farwaniya Hospital in Kuwait and Boston Children's Hospital studied the impact of a 50-minute delay in high school start times in one of the largest school districts in the U.S.
Vertex Pharmaceuticals Incorporated announced today that the European Commission has approved KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces the publication of an article, entitled "A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series," authored by Dr. Matthew C. Foote, Dr. Bryan H. Burmeister, Janine Thomas, and Dr. B. Mark Smithers, in the current issue of the peer-reviewed journal, Melanoma Research (20(1):48-51, February 2010).
Luisa Iruela-Arispe, PhD, the Stephen Walter Ranson Professor of Cell Biology and chair of Cell and Developmental Biology, is the North American coordinator for an international collaboration that has received a five-year, $7 million Transatlantic Networks of Excellence Program award from the Leducq Foundation.
› Verified 5 days ago
Dr. Alison Marie Small, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 3303 Sw Bond Ave, Portland, OR 97239 Phone: 503-418-3376 | |
Milie Fang, DO Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3303 S Bond Ave Dept, Portland, OR 97239 Phone: 503-494-1375 | |
Bert G Tavelli, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2525 Nw Lovejoy St Ste 400, Portland, OR 97210 Phone: 503-223-1933 Fax: 503-223-1947 | |
Natasha Fewkes Carter, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4914 Sw 1st Ave, Portland, OR 97239 Phone: 310-701-8274 | |
Dr. Samuel Fritz Bremmer, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-8211 | |
Oluwadamilare Olalekan Ajayi, MD Dermatology Medicare: Medicare Enrolled Practice Location: 3303 S Bond Ave, Portland, OR 97239 Phone: 503-418-3376 Fax: 503-494-6968 | |
Diane Romayne Baker, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 9495 Sw Locust St Ste A&e, Portland, OR 97223 Phone: 503-471-0500 Fax: 503-471-0504 |